Barclays’s Hinge Health HNGE Stock Holding History

Barclays’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.3M	Sell	208,433 -7,317	-3%	-$397K	﹤0.01%	1211
2026 Q1	$8.32M	Buy	215,750 +44,562	+26%	+$1.85M	﹤0.01%	1551
2025 Q4	$7.95M	Buy	171,188 +170,122	+15,959%	+$8.19M	﹤0.01%	1867
2025 Q3	$52.3K	Buy	+1,066	New	+$55.8K	﹤0.01%	4755

Other funds holding HNGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

12CM

11.2 Capital Management Las Vegas, Nevada $205M AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Barclays's HNGE Position: Q2 2026 in Review

Barclays reduced its Hinge Health (HNGE) stake by 3.4% in Q2 2026, selling an estimated $397K and leaving 208,433 shares worth $17.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1211.

Barclays first reported a position in HNGE in Q3 2025 and has held it in 4 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

Barclays held 208,433 shares of Hinge Health worth $17.3M as of Q2 2026.
Barclays sold 7,317 Hinge Health shares in Q2 2026, an estimated $397K.
Hinge Health made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1211 holding.
Barclays first reported a position in Hinge Health in Q3 2025 and has held it in 4 quarters since.
277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.